Literature DB >> 29719188

Follow-up of Patients with Clear-Cell Adenocarcinoma of the Vagina and Cervix.

Dezheng Huo1, Diane Anderson1, Arthur L Herbst1.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2018        PMID： 29719188      PMCID： PMC5972034          DOI： 10.1056/NEJMc1800097

Source DB:  PubMed          Journal:  N Engl J Med        ISSN： 0028-4793            Impact factor:   91.245


× No keyword cloud information.
  5 in total

Review 1.  Behavior of estrogen-associated female genital tract cancer and its relation to neoplasia following intrauterine exposure to diethylstilbestrol (DES).

Authors:  A L Herbst
Journal:  Gynecol Oncol       Date:  2000-02       Impact factor: 5.482

2.  Effects of estrogen receptor expression and histopathology on annual hazard rates of death from breast cancer.

Authors:  William F Anderson; Bingshu E Chen; Ismail Jatoi; Philip S Rosenberg
Journal:  Breast Cancer Res Treat       Date:  2006-05-10       Impact factor: 4.872

3.  Incidence rates and risks of diethylstilbestrol-related clear-cell adenocarcinoma of the vagina and cervix: Update after 40-year follow-up.

Authors:  Dezheng Huo; Diane Anderson; Julie R Palmer; Arthur L Herbst
Journal:  Gynecol Oncol       Date:  2017-07-06       Impact factor: 5.482

4.  Adverse health outcomes in women exposed in utero to diethylstilbestrol.

Authors:  Robert N Hoover; Marianne Hyer; Ruth M Pfeiffer; Ervin Adam; Brian Bond; Andrea L Cheville; Theodore Colton; Patricia Hartge; Elizabeth E Hatch; Arthur L Herbst; Beth Y Karlan; Raymond Kaufman; Kenneth L Noller; Julie R Palmer; Stanley J Robboy; Robert C Saal; William Strohsnitter; Linda Titus-Ernstoff; Rebecca Troisi
Journal:  N Engl J Med       Date:  2011-10-06       Impact factor: 91.245

5.  Influence of in utero diethylstilbestrol exposure on the prognosis and biologic behavior of vaginal clear-cell adenocarcinoma.

Authors:  S E Waggoner; R Mittendorf; N Biney; D Anderson; A L Herbst
Journal:  Gynecol Oncol       Date:  1994-11       Impact factor: 5.482
  5 in total
  4 in total

Review 1.  Susceptibility to adverse drug reactions.

Authors:  Robin Ferner; Jeffrey Aronson
Journal:  Br J Clin Pharmacol       Date:  2019-07-17       Impact factor: 4.335

2.  Napsin-A and AMACR are Superior to HNF-1β in Distinguishing Between Mesonephric Carcinomas and Clear Cell Carcinomas of the Gynecologic Tract.

Authors:  Jennifer Pors; Sheila Segura; Angela Cheng; Jennifer X Ji; Basile Tessier-Cloutier; Dawn Cochrane; Daniel J Fix; Kay Park; Blake Gilks; Lynn Hoang
Journal:  Appl Immunohistochem Mol Morphol       Date:  2020-09

3.  POLE-mutated clear cell cervical cancer associated with in-utero diethylstilbestrol exposure.

Authors:  Elizabeth K Lee; Neal I Lindeman; Ursula A Matulonis; Panagiotis A Konstantinopoulos
Journal:  Gynecol Oncol Rep       Date:  2019-01-29

Review 4.  The Impact of Endocrine-Disrupting Chemicals in Male Fertility: Focus on the Action of Obesogens.

Authors:  Luís Rato; Ana C A Sousa
Journal:  J Xenobiot       Date:  2021-11-29
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.